Literature DB >> 3796612

Generation of infectious Moloney murine leukemia viruses with deletions in the U3 portion of the long terminal repeat.

R Hanecak, S Mittal, B R Davis, H Fan.   

Abstract

Deletional analysis within the long terminal repeat (LTR) of Moloney murine leukemia virus (M-MuLV) was performed. By molecular cloning, deletions were made in the vicinity of the XbaI site at -150 base pairs (bp) in the U3 region, between the tandemly repeated enhancers and the TATA box. The effects of the deletions on LTR function were measured in two ways. First, deleted LTRs were fused to the bacterial chloramphenicol acetyltransferase gene and used in transient expression assays. Second, infectious M-MuLVs were generated by transfection of M-MuLV proviruses containing the deleted LTRs, and the relative infectivity of the mutant viruses was assessed by XC-syncytial assay. Most of the deleted LTRs examined showed relatively high promoter activity in the transient chloramphenicol acetyltransferase assays, with values ranging from 20 to 50% of the wild-type M-MuLV LTR. Thus, the sequences between the enhancers and the TATA box were not absolutely required for transient expression. However, infectivity of viruses carrying the same deleted LTRs showed more pronounced effects. Deletion of sequences from -195 to -174 bp reduced infectivity 20- to 100-fold. Deletion of sequences within the region from -174 to -122 bp did not affect infectivity, indicating that this region is dispensable. On the other hand, deletion of sequences from -150 to -40 bp reduced infectivity from 5 to 6 logs, although the magnitude of the reduction partly may have reflected threshold envelope protein requirements for positive XC assays. The reduced infectivity did not appear to result from a failure of proviral DNA synthesis or integration by the mutant. Thus, the infectivity measurements identified three functional domains in the region between the enhancers and the TATA box.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3796612      PMCID: PMC367248          DOI: 10.1128/mcb.6.12.4634-4640.1986

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  19 in total

1.  Synthesis of the precursor to avian RNA tumor virus internal structural proteins early after infection.

Authors:  B M Gallis; R N Eisenman; H Diggelmann
Journal:  Virology       Date:  1976-10-15       Impact factor: 3.616

2.  A new method for sequencing DNA.

Authors:  A M Maxam; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1977-02       Impact factor: 11.205

3.  Host-specific activation of transcription by tandem repeats from simian virus 40 and Moloney murine sarcoma virus.

Authors:  L A Laimins; G Khoury; C Gorman; B Howard; P Gruss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-11       Impact factor: 11.205

4.  Long terminal repeat of murine retroviral DNAs: sequence analysis, host-proviral junctions, and preintegration site.

Authors:  C Van Beveren; E Rands; S K Chattopadhyay; D R Lowy; I M Verma
Journal:  J Virol       Date:  1982-02       Impact factor: 5.103

5.  An SV40 deletion mutant accumulates late transcripts in a paranuclear extract.

Authors:  R Campos; L P Villarreal
Journal:  Virology       Date:  1982-05       Impact factor: 3.616

6.  Plaque assay techniques for murine leukemia viruses.

Authors:  W P Rowe; W E Pugh; J W Hartley
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

7.  Delineation of transcriptional control signals within the Moloney murine sarcoma virus long terminal repeat.

Authors:  B J Graves; R N Eisenman; S L McKnight
Journal:  Mol Cell Biol       Date:  1985-08       Impact factor: 4.272

8.  Low-multiplicity infection of Moloney murine leukemia virus in mouse cells: effect on number of viral DNA copies and virus production in producer cells.

Authors:  H Fan; R Jaenisch; P MacIsaac
Journal:  J Virol       Date:  1978-12       Impact factor: 5.103

9.  gag-Related polyproteins of Moloney murine leukemia virus: evidence for independent synthesis of glycosylated and unglycosylated forms.

Authors:  S A Edwards; H Fan
Journal:  J Virol       Date:  1979-05       Impact factor: 5.103

10.  Quantitative studies of the growth of mouse embryo cells in culture and their development into established lines.

Authors:  G J TODARO; H GREEN
Journal:  J Cell Biol       Date:  1963-05       Impact factor: 10.539

View more
  12 in total

1.  Contributions to transcriptional activity and to viral leukemogenicity made by sequences within and downstream of the MCF13 murine leukemia virus enhancer.

Authors:  J C Tupper; H Chen; E F Hays; G C Bristol; F K Yoshimura
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  Murine leukemia virus glycosylated Gag (gPr80gag) facilitates interferon-sensitive virus release through lipid rafts.

Authors:  Takayuki Nitta; Yurii Kuznetsov; Alexander McPherson; Hung Fan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-28       Impact factor: 11.205

3.  An embryonic DNA-binding protein specific for the promoter of the retrovirus long terminal repeat.

Authors:  F Flamant; C C Gurin; J A Sorge
Journal:  Mol Cell Biol       Date:  1987-10       Impact factor: 4.272

4.  Distinct segments within the enhancer region collaborate to specify the type of leukemia induced by nondefective Friend and Moloney viruses.

Authors:  E Golemis; Y Li; T N Fredrickson; J W Hartley; N Hopkins
Journal:  J Virol       Date:  1989-01       Impact factor: 5.103

5.  Tandemization of a subregion of the enhancer sequences from SRS 19-6 murine leukemia virus associated with T-lymphoid but not other leukemias.

Authors:  S W Granger; L M Bundy; H Fan
Journal:  J Virol       Date:  1999-09       Impact factor: 5.103

6.  Substitution of murine transthyretin (prealbumin) regulatory sequences into the Moloney murine leukemia virus long terminal repeat yields infectious virus with altered biological properties.

Authors:  G Feuer; H Fan
Journal:  J Virol       Date:  1990-12       Impact factor: 5.103

7.  Replication of enhancer-deficient amphotropic murine leukemia virus in human cells.

Authors:  F U Reuss; B Berdel; M Ploss; R Heber
Journal:  Proc Natl Acad Sci U S A       Date:  2001-09-04       Impact factor: 11.205

8.  Two blocks in Moloney murine leukemia virus expression in undifferentiated F9 embryonal carcinoma cells as determined by transient expression assays.

Authors:  G Feuer; M Taketo; R C Hanecak; H Fan
Journal:  J Virol       Date:  1989-05       Impact factor: 5.103

9.  Atomic force microscopy investigation of fibroblasts infected with wild-type and mutant murine leukemia virus (MuLV).

Authors:  Yurii G Kuznetsov; Shoibal Datta; Natantara H Kothari; Aaron Greenwood; Hung Fan; Alexander McPherson
Journal:  Biophys J       Date:  2002-12       Impact factor: 4.033

10.  Deletion of a GC-rich region flanking the enhancer element within the long terminal repeat sequences alters the disease specificity of Moloney murine leukemia virus.

Authors:  R Hanecak; P K Pattengale; H Fan
Journal:  J Virol       Date:  1991-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.